365 related articles for article (PubMed ID: 37154876)
1. Role of cuproptosis in understanding diseases.
Cao S; Wang Q; Sun Z; Zhang Y; Liu Q; Huang Q; Ding G; Jia Z
Hum Cell; 2023 Jul; 36(4):1244-1252. PubMed ID: 37154876
[TBL] [Abstract][Full Text] [Related]
2. Copper homeostasis and cuproptosis in health and disease.
Chen L; Min J; Wang F
Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of cuproptosis in Parkinson's disease.
Huang M; Zhang Y; Liu X
Ageing Res Rev; 2024 Mar; 95():102214. PubMed ID: 38311254
[TBL] [Abstract][Full Text] [Related]
4. Copper homeostasis and cuproptosis in cancer immunity and therapy.
Liu WQ; Lin WR; Yan L; Xu WH; Yang J
Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
[TBL] [Abstract][Full Text] [Related]
5. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.
Abdullah KM; Kaushal JB; Takkar S; Sharma G; Alsafwani ZW; Pothuraju R; Batra SK; Siddiqui JA
Heliyon; 2024 Mar; 10(5):e27496. PubMed ID: 38486750
[TBL] [Abstract][Full Text] [Related]
6. Cuproptosis: mechanisms and links with cancers.
Xie J; Yang Y; Gao Y; He J
Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
[TBL] [Abstract][Full Text] [Related]
7. Emerging insights into cuproptosis and copper metabolism: implications for age-related diseases and potential therapeutic strategies.
Fan H; Wang K; Zhao X; Song B; Yao T; Liu T; Gao G; Lu W; Liu C
Front Aging Neurosci; 2024; 16():1335122. PubMed ID: 38715962
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.
Liu N; Chen M
Biomed Pharmacother; 2024 Feb; 171():116115. PubMed ID: 38181713
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
[TBL] [Abstract][Full Text] [Related]
10. Cuproptosis-a potential target for the treatment of osteoporosis.
Li D; Gao Z; Li Q; Liu X; Liu H
Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
[TBL] [Abstract][Full Text] [Related]
11. Cuproptosis: p53-regulated metabolic cell death?
Xiong C; Ling H; Hao Q; Zhou X
Cell Death Differ; 2023 Apr; 30(4):876-884. PubMed ID: 36755067
[TBL] [Abstract][Full Text] [Related]
12. Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases.
Zou Y; Wu S; Xu X; Tan X; Yang S; Chen T; Zhang J; Li S; Li W; Wang F
Int Immunopharmacol; 2024 May; 133():112075. PubMed ID: 38663316
[TBL] [Abstract][Full Text] [Related]
13. Cuproptosis is involved in copper-induced hepatotoxicity in chickens.
Zhong G; Li L; Li Y; Ma F; Liao J; Li Y; Zhang H; Pan J; Hu L; Tang Z
Sci Total Environ; 2023 Mar; 866():161458. PubMed ID: 36621474
[TBL] [Abstract][Full Text] [Related]
14. An Intelligent Cell-Derived Nanorobot Bridges Synergistic Crosstalk Between Sonodynamic Therapy and Cuproptosis to Promote Cancer Treatment.
Chen K; Zhou A; Zhou X; Liu Y; Xu Y; Ning X
Nano Lett; 2023 Apr; 23(7):3038-3047. PubMed ID: 36951267
[TBL] [Abstract][Full Text] [Related]
15. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression.
Zhao Q; Qi T
Front Oncol; 2023; 13():1117164. PubMed ID: 36925927
[TBL] [Abstract][Full Text] [Related]
16. Cuproptosis in cancers: Function and implications from bench to bedside.
Huang XY; Shen JY; Huang K; Wang L; Sethi G; Ma Z
Biomed Pharmacother; 2024 Jul; 176():116874. PubMed ID: 38850661
[TBL] [Abstract][Full Text] [Related]
17. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
[TBL] [Abstract][Full Text] [Related]
18. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma.
Wang B; Song Q; Wei Y; Wu X; Han T; Bu H; Tang S; Qian J; Shao P
Front Immunol; 2022; 13():948042. PubMed ID: 36275737
[TBL] [Abstract][Full Text] [Related]
20. Cuproptosis and its application in different cancers: an overview.
Xu L; Liu K; Wang F; Su Y
Mol Cell Biochem; 2023 Dec; 478(12):2683-2693. PubMed ID: 36914880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
